Clinical Trials Logo

Filter by:
NCT ID: NCT05695794 Recruiting - Rhinoplasty Clinical Trials

The Effect of Different Bed Head Heights on Patients After Rhinoplasty

Start date: December 8, 2022
Phase: N/A
Study type: Interventional

This study will be conducted to evaluate the effect of different bed head heights (thirty degrees and forty-five degrees) given to patients after rhinoplasty surgery on periorbital edema, periorbital ecchymosis, respiratory function and sleep quality.

NCT ID: NCT05695742 Completed - Smoking Cessation Clinical Trials

Smoking Cessation Outcomes and Effective Factors

Start date: January 23, 2023
Phase:
Study type: Observational

The study is a cross-sectional-descriptive study. Cases who met the inclusion criteria, agreed to participate in the study voluntarily, were active smokers, passive smokers and non-smokers will be included. The subjects will be given the maximal voluntary breath-hold test, the 6-minute walk test, and the 30-second sit-and-stand test, and will be asked to answer questions about smoking. The physical conditions of the groups will be compared.

NCT ID: NCT05695625 Completed - Pain, Postoperative Clinical Trials

The Effect of Bilateral Erector Spina Plane Block on Postoperative Analgesia in Cesarean Section Under SpinalAnaesthesia

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

Acute pain after cesarean section (SC) can be variable. Untreated pain can affect patients' life quality. Currently regional nerve blocks are frequently used as a part of multimodal analgesia. Erector spina plane block (ESPB), a recently defined interfacial plane block, provides multisegmental analgesia by spreading to both ventral and dorsal branches of the spinal nerve roots in the cranio-caudal plane with a single injection. The aim of this study is to evaluate the effects of ESPB on postoperative pain, analgesic use and patient satisfaction in patients delivered by CS under spinal anesthesia.

NCT ID: NCT05695391 Recruiting - Hemophilia Clinical Trials

A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM

SCOPE HIM
Start date: June 7, 2024
Phase: Phase 3
Study type: Interventional

This is an interventional, prospective, international, multicenter, single-arm, Phase 3, and sequential efficacy and safety study in adolescents and adults with congenital hemophilia A or B with inhibitors to factor VIII (FVIII) or factor IX (FIX) undergoing elective major surgical procedures.

NCT ID: NCT05695274 Completed - Fibromyalgia Clinical Trials

Progressive Muscle Relaxation Exercises on Pain, Kinesiophobia and Functional Status

Start date: November 10, 2022
Phase: N/A
Study type: Interventional

Relaxation techniques are a non-pharmacological therapy option applied to alleviate the symptoms of many different chronic diseases. It has been reported in the literature that PMR is effective on pain, fatigue and stress symptoms in fibromyalgia patients. No study has been found examining the effect of PMR on kinesiophobia and functional status in FM. This study was planned to examine the effect of progressive muscle relaxation exercises on pain, kinesiophobia and functional status in fibromyalgia patients.

NCT ID: NCT05694910 Recruiting - Fatigue Clinical Trials

Reiki Effects on Bone Marrow Transplant Patients

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

The aim of the study is to examine the effect of Reiki on fatigue, vital signs, and engraftment in bone marrow transplant patients.

NCT ID: NCT05694676 Completed - Cerebral Palsy Clinical Trials

Relationship Between Prenatal Maternal Distress and the Quality of General Movements at 3 Months

Start date: February 17, 2023
Phase:
Study type: Observational

Depression and anxiety symptoms are common during pregnancy which may disturb the intrauterine environment by affecting the mother's physiological responses to stress, and ultimately impair fetal and postnatal development. There is increasing evidence about the effects of maternal distress on young brain tissue leading to some structural changes. The neurological footprints of these structural changes on the young brain may be caught early in life by a video assessment of General Movements (GMs) quality.

NCT ID: NCT05694390 Completed - Newborn Clinical Trials

The Effect of the Use of Sterile Transparent Film Dressing in Newborns

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

It is important that effective catheter fixation will reduce the risk of catheter unavailability for specific reasons and the incidence of catheter-related complications. The aim of this study was to determine the effect of sterile transparent film dressing and tape methods used in pe- ripheral intravenous catheter application in newborns on the duration of catheter stay and the development of catheter-related complications.

NCT ID: NCT05694208 Not yet recruiting - Gynecologic Cancer Clinical Trials

The Effect of Mobile-Based Education Given to Patients Undergoing Gynecological Oncology Surgery on Quality of Life

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

This study was planned in a randomized controlled prospective experimental design in order to determine the effect of mobile-based education given to patients undergoing gynecological oncology surgery on quality of life. Research Hypotheses: H1. Education given with mobile application in gynecological oncology patients positively affects symptom control of patients. H2. The education given with the mobile application in gynecological oncology patients positively affects the quality of life of the patients.

NCT ID: NCT05693935 Active, not recruiting - Schizophrenia Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia

SOLARIS
Start date: January 24, 2023
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the efficacy of TV-44749 in adult participants with schizophrenia. A key secondary objective is to further evaluate the efficacy of TV-44749 based on additional parameters in adult participants with schizophrenia. A secondary objective is to evaluate the safety and tolerability of TV-44749 in adult participants with schizophrenia Another secondary objective of this study is to evaluate the efficacy of TV-44749 from baseline to endpoint in Period 1 in adult participants with schizophrenia. Total study duration is up to 61 weeks, and treatment duration is up to 56 weeks, with weekly visits during the first 8 weeks and then monthly in-clinic visits with weekly calls during the remainder of the treatment period.